SMAD3 gene mutations were initially reported in patients presenting with aortic aneurysms and early-onset osteoarthritis (AOS), now referred to as LDS 3 with mild systemic features of MFS and LDS [76]. This evidence concerns the gene SMAD3 and Marfan syndrome.